Proteome-wide Profiling of Clinical PARP Inhibitors Reveals Compound-Specific Secondary Targets.

MLA

Knezevic, Claire E., et al. “Proteome-Wide Profiling of Clinical PARP Inhibitors Reveals Compound-Specific Secondary Targets.” Cell Chemical Biology, vol. 23, no. 12, Dec. 2016, pp. 1490–503. EBSCOhost, https://doi.org/10.1016/j.chembiol.2016.10.011.

APA

Knezevic, C. E., Wright, G., Rix, L. L. R., Kim, W., Kuenzi, B. M., Luo, Y., Watters, J. M., Koomen, J. M., Haura, E. B., Monteiro, A. N., Radu, C., Lawrence, H. R., & Rix, U. (2016). Proteome-wide Profiling of Clinical PARP Inhibitors Reveals Compound-Specific Secondary Targets. Cell Chemical Biology, 23(12), 1490–1503. https://doi.org/10.1016/j.chembiol.2016.10.011

Chicago

Knezevic, Claire E, Gabriela Wright, Lily L Remsing Rix, Woosuk Kim, Brent M Kuenzi, Yunting Luo, January M Watters, et al. 2016. “Proteome-Wide Profiling of Clinical PARP Inhibitors Reveals Compound-Specific Secondary Targets.” Cell Chemical Biology 23 (12): 1490–1503. doi:10.1016/j.chembiol.2016.10.011.